SUMMARY The response of peripheral blood lymphocytes (PBL) to autologous synovial fluid lymphocytes (SFL) from patients with rheumatoid arthritis and Reiter's syndrome was investigated in an autologous mixed lymphocyte reaction (AMLR). SFL were found to be poor responders but strong stimulators of autologous and allogeneic PBL compared with autologous PBL. The plastic-adherent (macrophage) cells from the SFL were found to be highly stimulatory to autologous PBL, particularly when the adherent cells were removed from the responding PBL. The stimulation of these PBL non-adherent cells by SFL adherent cells follows two main trends: either no stimulation, or higher stimulation than using unseparated SFL and PBL. Patients in the high stimulator group were taking non-steroidal anti-inflammatory drugs while those in the low responder group were taking, in addition, second-line drugs such as D-penicillamine or gold. Autologous serum was found to inhibit the AMLR and this is probably due to drug metabolites in patients' sera. Initial results show that the AMLR in individual patients is highly correlated, over time, with the erythrocyte sedimentation rate (ESR).
immunoregulation and altered AMLR. This study suggests such a relationship.
An impairment of the AMLR has been demonstrated in autoimmune disorders such as systemic lupus erythematosus, primary biliary cirrhosis, and Sjogren's syndrome,8 and in polymyositis/ dermatomyositis patients,9 conditions in which both cellular and humoral immunity are altered. Disturbances in immunoregulation have also been detected in rheumatoid arthritis (RA) and are believed to be due to a lack of suppressor T cell activity8 or T cell regression activity." An increased ratio of helper suppressor T cells with a concomitant presence of strongly DR' macrophage-like cells,"1 which allow autostimulation to persist, have also been described in RA patients. Thus the AMLR may be a useful in-vitro model for the investigation of cellular interactions important in immunoregulation in patients with RA or other forms of arthritis, such as Reiter's syndrome.
In this study the AMLR has been used to assay the proliferation of peripheral blood lymphocytes (PBL) in response to stimulation by autologous synovial fluid lymphocytes (SFL). Previous studies applying the AMLR of PBL to autologous SFL in RA patients have been equivocal about whether the AMLR is stimulated8 12 13 
Results
Cultures revealed that the optimal ratio of respon-
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x "'-300- der to stimulator cells was 1:1 and that the optimal response occurred on day 6 in both the AMLR and aMLR. SFL were found to be good stimulators in the AMLR but poor responders to PHA and allogeneic or autologous stimulation. The following results confirmed that the SFL were already activated: 3 The AMLR (mSFL/PBL) ofRA (@) and Reiter's disease patients (V) in pooled AB, and autologous serum is compared with the other autologous combination mPBLIPBL. RA and Reiter's disease patients who were not taking medication or who had medication withdrawn 48 hours prior to assay, are represented by open symbols (0, V). Shown are the mean (dpm)±SEM, and each point is the mean ofquadruplicate cultures. The mean incorporation for the AMLR ofRA patients is 30 000 dpm (Reiter's disease patients 43 500-dpm) in pooled AB serum, but only 3700 dpm in the autologous serum ofpatients on drugs (p<0-05). The AMLR is significantly larger (p<0-01) than mPBL/PBL (1500 dpm).
. group.bmj.com on June 6, 2017 -Published by http://ard.bmj.com/ Downloaded from (1) the increased incorporation of 3H-thymidine into resting SFL compared with autologous PBL was some three times greater on average (Fig. 1) ; (2) PHA stimulation of SFL was significantly lower compared with autologous PBL (p<0-01); (3) SFL as stimulators in the aMLR induced a significantly larger response than autologous PBL (p<0-001) (Fig. 2) ; and (4) SFL responded less than autologous PBL (p<0-005) to allogeneic cells (Fig. 2) .
In pooled AB serum (Fig. 3 ) the only cell combination that showed significant autologous stimulation was with mitomycin-C treated SFL as stimulator and PBL as responder (mSFL/PBL). The mean response of this AMLR was 30 000 dpm for patients with RA and 43 500 dpm for patients with Reiter's disease. This response was statistically larger than that for other autologous combinations such as mPBL/PBL, mSFL/SFLm and mC/C (RA, p<0-01; Reiter's disease, p<0-001). The patients with Reiter's disease showed less variation in their AMLR response than RA patients.
Cultures with sonicated SFL revealed negligible stimulation (mean incorporation 900 dpm) compared with the mean AMLR (30 000 dpm).
In nine out of 12 RA patients the addition of autologous serum severely decreased the AMLR to control levels, compared with pooled AB serum (p<005). This autologous serum was also found to suppress the response of lymphocytes to PHA stimulation. However, as shown in Fig. 3 , three patients with RA and three with Reiter's disease who had not taken any medication or who had ceased medication at least 48 h prior to assay had an AMLR which was relatively unchanged by incubation in autologous serum.
Removal of the adherent cells from the stimulating population (mSFL) in the AMLR caused a significant decrease in thymidine incorporation in eight of the 12 cultures of RA patients but was not significantly affected in four of the RA patients (Table 1 ). In these four cultures stimulation in the AMLR resided in the non-adherent fraction of SFL. The mean incorporation of these mSFL nonadherent/PBL mixtures was 14 829 dpm, about half of the unfractionated mSFV/PBL combination (27 706 dpm). Adherent cells removed from the responder PBL population when stimulated by unfractionated mSFL cells in the AMLR resulted in either a decreased, increased, or indifferent response (Table 1 ). In two of the 11 cultures from patients with RA there was a significant decrease in the AMLR response, while in six patients removal of the macrophages from the responding PBL population had no effect; but in three cultures there was a greatly increased response, far larger than the initial AMLR. The stimulation of PBL by PBL (adherent) cells was negligible (Table 2 ). In seven of the 10 RA patients the mean stimulation of PBL by autologous SFL (adherent) was 10 390 dpm, 10 times larger than PBL (adherent) cells, but significantly less than with unfractionated mSFL. In three cases the mSFL (adherent) cells were not significantly different, compared with mSFL, in their stimulating capacity (Table 2) . Tables 1 and 2 are different subjects. Since removal of the macrophages from the responding population caused an increased AMLR in some patients, mSFL (adherent) cells were incubated with PBL from which the adherent cells had been removed (Fig. 4) . In five patients this AMLR, mSFL (adherent)/PBL (non-adherent) was significantly reduced (mean 2600 dpm) as compared with a normal AMLR response (mC/C). In two cases (RA) the (0), r=0-98, p<0-05andpatient2 (-), r=0-97, p<0-05on threeseparate occasions.
cases (RA) the AMLR was markedly increased (mean 58 300 dpm).
The patients were now observed to form two distinct groups where the AMLR was altered with removal of PBL macrophages. Those patients in the upper response group all had very active disease and a recent increase in their ESR (greater than 20 mm/h). All three patients were taking NSAID and one patient took penicillamine. The lower group of patients were on gold or penicillamine, and only one patient out of five was taking NSAID alone. Their low AMLR correlated with a recent decrease in ESR.
Though the overall data showed no correlation of the AMLR with ESR, serum rheumatoid factor, or synovial fluid C-reactive protein at the time of assay, in two cases sequential studies revealed a significant correlation of ESR with the AMLR (Fig. 5) .
Discussion
In keeping with other studies employing surface markers and immunohistochemical stains of lymphocyte activation21 22 in RA the SFL in the present study were found to be significantly more activated than autologous PBL in both RA and Reiter's disease patients. The origin of the activated SFL in RA is uncertain, though it has been suggested that they arise from the superficial layer of synovium. 23 In Since previous investigators '4 3437 have found that autologous serum suppresses the AMLR, possibly because of the proved effect of drugs and their metabolites on the AMLR, it was decided to incubate cells in human pooled AB serum. AMLR patients with Reiter's syndrome were not affected significantly by the addition of autologous serum. Often these patients had only just commenced NSAID therapy, and perhaps this explains the lack of suppression of the AMLR by their serum. This may also explain the much reduced variability of their AMLR compared with that of RA patients. Because the AMLR of patients not on drug treatment was unaffected by autologous serum, the inhibitor in autologous serum is thought not to be an HLA-restricted suppressor factor.
In conclusion because of the demonstration of the AMLR and its correlation with an index of disease activity, this provides evidence in support of the AMLR as an in-vivo phenomenon important in the pathogenesis of RA. This study also suggests that the AMLR may be a useful index and predictor of future disease activity. The 
